A detailed history of Mbb Public Markets I LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mbb Public Markets I LLC holds 1,710 shares of ABBV stock, worth $307,800. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,710
Previous 126,376 98.65%
Holding current value
$307,800
Previous $21.7 Million 98.45%
% of portfolio
0.02%
Previous 0.45%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $20.4 Million - $24.8 Million
-124,666 Reduced 98.65%
1,710 $337,000
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $18.7 Million - $21.8 Million
120,819 Added 2174.18%
126,376 $21.7 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $888,119 - $1.01 Million
5,557 New
5,557 $1.01 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $1.77 Million - $2.2 Million
-13,445 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $1.44 Million - $1.83 Million
13,445 New
13,445 $1.82 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mbb Public Markets I LLC Portfolio

Follow Mbb Public Markets I LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbb Public Markets I LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbb Public Markets I LLC with notifications on news.